Sign up to save your podcasts
Or
Share Episode 725: Advancing Humane Cancer Therapy: GT Biopharma's ($GTBP) Next-Gen Immunotherapy & Clinical Progress
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 725: Advancing Humane Cancer Therapy: GT Biopharma's ($GTBP) Next-Gen Immunotherapy & Clinical Progress
A breakthrough that could reshape cancer treatment.
GT Biopharma (NASDAQ: GTBP) is advancing its next generation TriKE® platform, an innovative immunotherapy that activates the body’s own natural killer cells to identify and destroy cancer.
In this interview, Executive Chairman & CEO Michael Breen discusses the company’s latest clinical progress and the potential of its lead drug candidate, GTB-3650.
He also shares insights into the science behind TriKE®, the company’s pipeline for solid tumors and autoimmune diseases, and its mission to develop more humane cancer therapies that bring real hope to patients worldwide.
Learn more about GT Biopharma: https://www.gtbiopharma.com/
Watch the full YouTube interview here: https://youtu.be/jduKYNKHMIY
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia
View all episodes
By Global One Media
5
2222 ratings
A breakthrough that could reshape cancer treatment.
GT Biopharma (NASDAQ: GTBP) is advancing its next generation TriKE® platform, an innovative immunotherapy that activates the body’s own natural killer cells to identify and destroy cancer.
In this interview, Executive Chairman & CEO Michael Breen discusses the company’s latest clinical progress and the potential of its lead drug candidate, GTB-3650.
He also shares insights into the science behind TriKE®, the company’s pipeline for solid tumors and autoimmune diseases, and its mission to develop more humane cancer therapies that bring real hope to patients worldwide.
Learn more about GT Biopharma: https://www.gtbiopharma.com/
Watch the full YouTube interview here: https://youtu.be/jduKYNKHMIY
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia
More shows like Stocks To Watch
View all
Motley Fool Money
3,224 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,385 Listeners
Best Stocks Now with Bill Gunderson
362 Listeners
The Investing for Beginners Podcast - Your Path to Financial Freedom
1,413 Listeners
Wall Street Breakfast
1,038 Listeners
Stock Club
88 Listeners
Thoughts on the Market
1,301 Listeners
Saxo Market Call
127 Listeners
Here's Why
70 Listeners
Barron's Streetwise
1,560 Listeners
The Canadian Investor
78 Listeners
Investing Experts
67 Listeners
Stock Market Today With IBD
44 Listeners
The Rundown
411 Listeners
The Stocks and Savings Podcast
2 Listeners